How have liposomes been used as a treatment option for impetigo?
Best insight from top research papers
Liposomes have been used as a treatment option for impetigo. Liposomal PVP-iodine hydrogel has been investigated for its utility in treating infective dermatoses, including impetigo contagiosa . In a pilot study, patients with impetigo contagiosa received liposomal PVP-iodine hydrogel for up to 4 weeks, and improvements in the Global Clinical Severity score were observed . The treatment was well tolerated, with the most frequent adverse events being burning and itching sensations . This suggests that liposomal PVP-iodine hydrogel has potential as an effective treatment for impetigo contagiosa, a bacterial skin infection .
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
| The paper does not specifically mention the use of liposomes as a treatment option for impetigo. | |
| The provided paper does not mention the use of liposomes as a treatment option for impetigo. The paper focuses on the use of liposomes as a delivery system for the treatment of biofilm-mediated infections. | |
34 Citations | The provided paper does not mention the use of liposomes as a treatment option for impetigo. The paper focuses on the use of liposomes composed of biomaterials for the treatment of cancer. |
| The provided paper does not mention the use of liposomes as a treatment option for impetigo. | |
| The paper does not specifically mention the use of liposomes as a treatment option for impetigo. The paper discusses the use of liposomal antibiotics for the treatment of microbial infections in general. |
Related Questions
What is the role of liposomes in the treatment of rheumatoid arthritis (RA)?5 answersLiposomes play a crucial role in the treatment of rheumatoid arthritis (RA) by serving as effective drug delivery systems. These lipid-based nanoparticles can be functionalized with ligands to target specific sites, such as arthritic joints, enhancing drug efficacy and reducing adverse effects. Liposomes can overcome barriers like the stratum corneum, facilitating transdermal drug delivery for site-specific action and improved patient compliance. Additionally, liposomal formulations, like dextran sulfate-modified flexible liposomes, show high uptake by activated macrophages, leading to anti-inflammatory effects and improved joint swelling in RA models. Overall, liposomes offer a promising avenue for delivering therapeutic agents to target RA-related inflammation, cartilage degradation, and pain, potentially improving the outcomes of RA treatment.
How to prepare liposomes for topical cosmetic uses?5 answersTo prepare liposomes for topical cosmetic uses, various techniques can be employed. These include utilizing novel nanotechnologies like nanoliposomes for transcutaneous penetration of active ingredients, encapsulating essential oils (EOs) and fatty acids into liposomes for improved stability and controlled release, and forming liposomal gels through a pH-gradient method to enhance skin-layer retention of substances like monocrotaline (MCT) for topical administration. Additionally, the development of liposome artificial skin membranes based on liposome technology allows for the simulation of the skin corneum's composition and structure, providing a suitable substitute for in-vitro transdermal absorption experiments in cosmetics research and development. These methods offer efficient ways to enhance the effectiveness, stability, and skin retention of active ingredients in cosmetic formulations.
How do liposomes enhance the effectiveness of antifungal drugs in the treatment of dermatophytosis?5 answersLiposomes enhance the effectiveness of antifungal drugs in the treatment of dermatophytosis by improving drug delivery and targeting. Liposomes are lipid-based nanoparticles that can encapsulate antifungal drugs, such as griseofulvin, and deliver them to the site of infection. They have been shown to have high entrapment efficiency and drug release profiles, making them suitable carriers for antifungal agents. Liposomes can interact with fungal cells, such as Candida albicans, leading to high levels of liposome-fungal cell interaction and potentially increasing the efficacy of the antifungal drug. Additionally, liposomes can improve the retention of biomolecules in the upper layers of the skin, increasing the effectiveness of the drug in treating cutaneous fungal infections. Overall, liposomes offer a promising approach for enhancing the effectiveness of antifungal drugs in the treatment of dermatophytosis.
How is exosome therapy used to treat infectious diseases?5 answersExosome therapy is being explored as a potential treatment for infectious diseases. Exosomes are small extracellular vesicles that can transfer their contents, including RNAs, DNAs, proteins, and lipids, between cells and tissues, facilitating cell-to-cell communication. In the context of respiratory viral diseases, exosomes have shown potential as therapeutics for viral infections, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). They can target, bind, and suppress cellular uptake of various viruses, and progress has been made towards clinical translation for lung-derived exosome therapeutics. Exosomes have also been studied in the context of bacterial infections, where they can impact innate immune responses and contribute to inflammation. Furthermore, exosomes have the potential to be used as biomarkers for infectious diseases and as vaccines to prime the immune system. Overall, exosome therapy holds promise for the treatment of infectious diseases, including viral and bacterial infections.
How liposomes used in buccal drug delivery?3 answersLiposomes are used in buccal drug delivery to improve the bioavailability and therapeutic outcome of drugs. The buccal route of administration is considered patient-friendly and non-invasive, making it an attractive alternative to traditional oral delivery. However, the drug concentration absorbed in the buccal mucosa is often low due to various factors such as saliva turnover, enzymatic degradation, and lack of epithelium permeation. To overcome these challenges, liposomes can be used to encapsulate drugs and protect them from degradation, improving their delivery through the buccal mucosa. Liposomes are microparticulate colloidal vesicles composed of phospholipids and can incorporate both hydrophilic and hydrophobic drugs. They offer controlled release and targeted drug delivery, enhancing therapeutic efficacy and reducing dosing frequency. Liposomes can also improve the oral absorption of drugs by increasing permeability and bioavailability via the gastrointestinal tract. The use of liposomes in buccal drug delivery can be further enhanced by functionalizing their surface using layer-by-layer assembly technology, which can improve stability and efficiency in intestinal absorption.
How are liposomes used in the delivery of drugs to treat breast cancer?5 answersLiposomes are used in the delivery of drugs to treat breast cancer by improving drug solubility, stability, and targeted delivery. Liposomes can solubilize drugs such as paclitaxel (PTX) and dihydroartemisinin, enhancing their efficacy and patient tolerance. Different lipids can be conjugated to the drugs to optimize drug release and enzymatic conversion rates, leading to improved pharmacokinetics, tumor accumulation, and anti-tumor efficacy. Ginsenoside Rg_3-based liposomes loaded with dihydroartemisinin and paclitaxel showed higher inhibition rates on breast cancer cells compared to free drugs. pH-responsive and biodegradable calcium orthophosphate@liposomes (CaP@Lip) nanoparticles loaded with paclitaxel and doxorubicin hydrochloride achieved excellent drug loading efficiencies and demonstrated high targeting ability to tumor sites. Liposomes can also be used in combination with other therapies, such as immunotherapy and photothermal therapy, for the treatment of breast cancer.